Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | NPBWR1 | P48145 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | MITF | O75030 | 1/20 | 0.39 |
| ▸ | NSD2 | O96028 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | GALK1 | P51570 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1834351 | 0.82 | TSHR (0.50) | TRPA1TSHRNPSR1GAANPBWR1 | |
| SCHEMBL475639 | 0.82 | TSHR (0.50) | TRPA1TSHRNPSR1GAANPBWR1 | |
| SCHEMBL1639928 | 0.82 | TSHR (0.50) | TRPA1TSHRNPSR1GAANPBWR1 | |
| Bromide SCHEMBL7457265 | 0.81 | TSHR (0.49) | TRPA1TSHRNPSR1GAANPBWR1 | |
| SCHEMBL10962781 | 0.78 | TRPA1 (0.42) | TRPA1TSHRNPSR1GAANPBWR1 | |
| SCHEMBL31440887 | 0.78 | ALDH1A1 (0.35) | TDP1ALDH1A1 | |
| SCHEMBL9841001 | 0.77 | TRPA1 (0.42) | TRPA1TSHRNPSR1GAANPBWR1 | |
| Hydrochloric Acid SCHEMBL3028478 | 0.76 | SIGMAR1 (0.50) | SIGMAR1 | |
| SCHEMBL7322626 | 0.76 | TRPA1 (0.53) | TRPA1OPRM1OPRD1OPRK1SIGMAR1 | |
| SCHEMBL7320183 | 0.76 | TRPA1 (0.53) | TRPA1OPRM1OPRD1OPRK1SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 274 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250354050-A1 | COMBINATION PRODUCTS CONTAINING ANTI-AGGLOMERANT LOW DOSE HYDRATE INHIBITORS AND CORROSION INHIBITORS WITH IMPROVED CORROSION RESISTANCE | CHAMPIONX LLC (US) | 2025-11-20 | — | — | US | claimed |
| US-9833002-B2 | Biocide compositions | ECOLAB USA INC. (US) | 2017-12-05 | — | — | US | claimed |
| US-20160374346-A1 | BIOCIDE COMPOSITIONS | NORRISEAL-WELLMARK, INC. | 2016-12-29 | — | — | US | claimed |
| US-9374999-B2 | Biocide compositions | ECOLAB USA INC. (US) | 2016-06-28 | — | — | US | claimed |
| EP-3027027-A1 | BIOCIDE COMPOSITIONS | Ecolab USA Inc. (US) | 2016-06-08 | — | — | EP | claimed |
| CN-105451555-A | Biocide composition | ECOLAB USA INC | 2016-03-30 | — | — | CN | claimed |
| US-20150034319-A1 | H2S SCAVENGERS WITH SYNERGISTIC CORROSION INHIBITION | BAKER HUGHES INCORPORATED (US) | 2015-02-05 | — | — | US | claimed |
| US-20150038470-A1 | BIOCIDE COMPOSITIONS | NORRIS RODS, INC., | 2015-02-05 | — | — | US | claimed |
| WO-2015017705-A1 | BIOCIDE COMPOSITIONS | ECOLAB USA INC. (US) | 2015-02-05 | — | — | WO | claimed |
| US-8022017-B2 | Method of using dithiazine to inhibit corrosion | BAKER HUGHES INCORPORATED (US) | 2011-09-20 | — | — | US | claimed |
| US-20110152137-A1 | METHOD OF USING CORROSION INHIBITORS DERIVED FROM SPENT FLUIDS IN THE TREATMENT OF WELLS | BAKER HUGHES HOLDINGS LLC | 2011-06-23 | — | — | US | claimed |
| EP-4735666-A2 | CORROSION INHIBITOR HAVING CARBON-BASED NANOPARTICLES | ChampionX LLC (US) | 2026-05-06 | — | — | EP | disclosed |
| EP-4731726-A1 | CORROSION INHIBITOR COMPOSITIONS AND METHODS OF USING THE SAME | ChampionX LLC (US) | 2026-04-29 | — | — | EP | disclosed |
| US-12571328-B2 | Turbine deposit cleaner | ECOLAB USA INC. (US) | 2026-03-10 | — | — | US | disclosed |
| EP-3844112-B1 | USE OF MULTIPLE CHARGED CATIONIC COMPOUNDS DERIVED FROM PRIMARY AMINES OR POLYAMINES FOR MICROBIAL FOULING CONTROL IN A WATER SYSTEM | ECOLAB USA INC (US) | 2026-02-25 | — | — | EP | disclosed |
| US-20110152137-A1 | METHOD OF USING CORROSION INHIBITORS DERIVED FROM SPENT FLUIDS IN THE TREATMENT OF WELLS | BAKER HUGHES HOLDINGS LLC | 2011-06-23 | — | — | US | disclosed |
| US-20110152131-A1 | Method of Using Dithiazines and Derivatives Thereof in the Treatment of Wells | BAKER HUGHES HOLDINGS LLC | 2011-06-23 | — | — | US | disclosed |
| CN-101828569-A | Herbicidal composition | ISHIHARA SANGYO KAISHA | 2010-09-15 | — | — | CN | disclosed |
| CN-101022731-B | Herbicidal composition | ISHIHARA SANGYO KAISHA | 2010-06-16 | — | — | CN | disclosed |
| CN-101022731-A | Herbicidal composition | ISHIHARA SANGYO KAISHA (JP) | 2007-08-22 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110152131-A1 | Method of Using Dithiazines and Derivatives Thereof in the Treatment of Wells | F12, ALOX5, FFAR3 | TRPA1 420/4885TSHR 127/4885NPSR1 1151/4885 |
| US-12571328-B2 | Turbine deposit cleaner | PUF60, PARG, FGB | TRPA1 19/4885TSHR 1075/4885NPSR1 2062/4885 |
| US-20150038470-A1 | BIOCIDE COMPOSITIONS | ABHD6, MGLL, GUSB | TRPA1 934/4885TSHR 4792/4885NPSR1 3007/4885 |
| US-20160374346-A1 | BIOCIDE COMPOSITIONS | ABHD6, MGLL, GUSB | TRPA1 934/4885TSHR 4792/4885NPSR1 3007/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.